Insider Trading & Ownership - Chanda Sanjay

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Chanda Sanjay
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2025-01-03
Sale		2025-01-07
8:00 pm		AN2 Therapeutics Inc.ANTXChanda Sanjay
Chief Development Officer		2,957$1.341$3,96529,824
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2025-02-26
Option Award		2025-02-28
4:27 pm		N/A
2035-02-25		AN2 Therapeutics Inc.ANTXChanda Sanjay
Chief Development Officer		150,750$0180,574
(Direct)		View
2024-03-15
Option Award(A)		2024-03-29
4:16 pm		N/A
N/A		AN2 Therapeutics Inc.ANTXChanda Sanjay
Chief Development Officer		27,500$028,235
(Direct)		View
2024-03-15
Option Award		2024-03-18
7:27 pm		N/A
2034-03-14		AN2 Therapeutics Inc.ANTXChanda Sanjay
Chief Development Officer		82,500$083,235
(Direct)		View
2023-02-15
Option Award		2023-02-17
7:28 pm		N/A
2033-02-14		AN2 Therapeutics Inc.ANTXChanda Sanjay
Chief Development Officer		57,950$057,950
(Direct)		View
2022-05-12
Option Award		2022-05-16
9:32 pm		N/A
2032-05-11		AN2 Therapeutics Inc.ANTXChanda Sanjay
Chief Development Officer		66,000$066,000
(Direct)		View

Ownership		2022-03-24
9:19 pm		N/A
2030-01-22		AN2 Therapeutics Inc.ANTXChanda Sanjay
Chief Development Officer		0$0141,581
(Direct)		View
(A) Indicate amendment filing.